Becton Dickinson hikes dividend by 9.5% | Biggest increase since 2016
Becton Dickson (BDX) will increase its dividend by 9.5% to $1.04 quarterly per share in 2024. This is the 53rd year in a row that the medical technology company's dividend has been increased. Its the biggest dividend hike by BDX since 2016.
The dividend will be payable on December 31, 2024 to holders of record on December 9, 2024. The indicated annual dividend rate for fiscal year 2025 is $4.16 per share.
"This is the 53rd consecutive fiscal year in which we have raised our dividend, maintaining BD's membership in the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends for at least 25 consecutive years," said Tom Polen, chairman, CEO and president or BD. "This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value through execution of our BD 2025 strategy and return capital to shareholders."
Last year Becton hiked the dividend by 4.4%. The last double digit dividend hike dates back to 2016. The dividend yield for BDX is 1.8% at a stock price of $227.
Becton Dickinson is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. Products include syringes, needles, insulin delivery systems, diagnostic equipment, bioscience tools, preanalytical systems, infection prevention solutions, and surgical/interventional products.
